Literature DB >> 18795068

Modulation of UCP2 expression by p38--a link to cardioprotection.

Eva Valouskova1, Martin Modriansky.   

Abstract

BACKGROUND: Discovery of uncoupling protein 2 (UCP2) in 1997 and demonstration of its wide tissue expression has triggered an important question about controlled oxidative phosphorylation uncoupling and the physiological function of this process. Uncoupling protein 2 (UcP2) is a mitochondrial protein that can influence the mitochondrial membrane potential and hence the production of reactive oxygen species by mitochondria. It is also thought to be involved in apoptotic signaling pathways and it has been suggested to be important in cardio- and neuroprotection. METHODS AND
RESULTS: We examined the recent literature (2003-2007) in the MedLine database for evidence linking p38, one of the stress-related protein kinases, with modulation of UCP2 expression in the heart. While two reports clearly demonstrate p38 as down-regulating UcP2 expression, only circumstantial evidence exists for cardiomyocytes. Conflicting results on p38-regulated cardiomyocyte survival after ischemia leave an open venue for hypotheses on the differential regulation of protein expression, including UCP2.
CONCLUSIONS: Reviewing the evidence connecting UCP2 and its cytoprotective activities, we propose a tissue specific link that may explain the variable influence of p38 via modulation of UCP2 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795068     DOI: 10.5507/bp.2008.001

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  3 in total

Review 1.  Uncouple my heart: the benefits of inefficiency.

Authors:  Martin Modrianský; Eva Gabrielová
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

2.  Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia.

Authors:  Peng Zhao; Jingying Wang; Leilei He; Heng Ma; Xiaoyu Zhang; Xinglei Zhu; E Kurt Dolence; Jun Ren; Ji Li
Journal:  J Cell Mol Med       Date:  2009-06-05       Impact factor: 5.310

3.  Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression.

Authors:  Chunyan Yang; Dongming Zhao; Guohui Liu; Haikuo Zheng; Hongliang Yang; Sibao Yang; Ping Yang
Journal:  Int J Med Sci       Date:  2018-03-08       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.